Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
n,n-dimethylphenethylamine
- Development stage
- Preclinical
- Modality
- Small Molecules
- Administration
- Oral, Ophthalmic
01
Overview
n,n-dimethylphenethylamine (also known as N,N-DMPEA or n-phenethyl dimethylamine) is a substituted phenethylamine alkaloid and a small molecule neuromodulator. Naturally occurring in the orchid *Eria jarensis*, it is primarily utilized as an ingredient in dietary supplements, specifically pre-workout and fat-burning formulations, where it is purported to enhance energy, focus, and athletic performance. The compound is believed to increase synaptic concentrations of dopamine and noradrenaline, acting as a central nervous system stimulant. While it has been investigated for potential therapeutic use in ophthalmic solutions for dry eye conditions, it is not currently an approved pharmaceutical drug and is banned by the World Anti-Doping Agency (WADA) for use in competitive sports.
- Other names
- N,N-DMPEAn-phenethyl dimethylamineEria jarensis extractN,N-dimethyl-2-phenylethan-1-amine
02
Targets
TAAR1 (Trace amine-associated receptor 1)HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))
Beyond the preview
Go deeper on n,n-dimethylphenethylamine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on n,n-dimethylphenethylamine.